doi:10.1177/0391560318802160
However, both compounds individually cause: Nausea (60-80% of users at higher doses) Vomiting (20-35%) Diarrhea (25-40%) Injection site reactions (15-25%) Potential pancreatitis (rare but serious) Combining these compounds could theoretically amplify these effects, though the actual incidence and severity remain unstudied
Oral TB-500 is not commonly used
Research has primarily focused on its utility in orthopedic applications, gastrointestinal healing, and trauma-related recovery, though its broader implications remain under active investigation
Most patients experience no adverse effects beyond improved sleep quality
Origin: Where the Research Comes From BPC-157 was first isolated and characterized as a fragment of a larger ~40-kDa cytoprotective protein identified in human gastric juice by Predrag Sikiric and colleagues at the University of Zagreb, Croatia